View in EDS HTML Full Text PDF Full Text

PUNCH CD3-OLS: A Phase 3 Prospective Observational Cohort Study to Evaluate the Safety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTA) in Adults With Recurrent Clostridioides difficile Infection.

Saved in:
Bibliographic Details
Title: PUNCH CD3-OLS: A Phase 3 Prospective Observational Cohort Study to Evaluate the Safety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTA) in Adults With Recurrent Clostridioides difficile Infection.
Authors: Feuerstadt P; Digestive Diseases, Yale School of Medicine, New Haven, Connecticut, USA., Chopra T; Division of Infectious Diseases, Wayne State University, Detroit, Michigan, USA., Knapple W; Arkansas Gastroenterology, North Little Rock, Arkansas, USA., Van Hise NW; Metro Infectious Disease Consultants, Burr Ridge, Illinois, USA., Dubberke ER; Division of Infectious Diseases, Washington University School of Medicine, Saint Louis, Missouri, USA., Baggott B; Department of Gastroenterology, Hepatology and Nutrition, Cleveland Clinic, Cleveland, Ohio, USA., Guthmueller B; Global Clinical and Translational Sciences, Ferring Pharmaceuticals, Roseville, Minnesota, USA., Bancke L; Global Clinical and Translational Sciences, Ferring Pharmaceuticals, Roseville, Minnesota, USA.; Global Clinical Operations US, Ferring Pharmaceuticals, Roseville, Minnesota, USA., Gamborg M; Global Biometrics, Ferring Pharmaceuticals, Copenhagen, Denmark., Steiner TS; Division of Infectious Diseases, University of British Columbia, Vancouver, Canada., Van Handel D; MNGI Digestive Health, Plymouth, Minnesota, USA., Khanna S; Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2025 Feb 05; Vol. 80 (1), pp. 43-51.
Publication Type: Journal Article; Clinical Trial, Phase III; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39180326
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: PUNCH CD3-OLS: A Phase 3 Prospective Observational Cohort Study to Evaluate the Safety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTA) in Adults With Recurrent Clostridioides difficile Infection.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Feuerstadt+P%22">Feuerstadt P</searchLink>; Digestive Diseases, Yale School of Medicine, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Chopra+T%22">Chopra T</searchLink>; Division of Infectious Diseases, Wayne State University, Detroit, Michigan, USA.<br /><searchLink fieldCode="AU" term="%22Knapple+W%22">Knapple W</searchLink>; Arkansas Gastroenterology, North Little Rock, Arkansas, USA.<br /><searchLink fieldCode="AU" term="%22Van+Hise+NW%22">Van Hise NW</searchLink>; Metro Infectious Disease Consultants, Burr Ridge, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Dubberke+ER%22">Dubberke ER</searchLink>; Division of Infectious Diseases, Washington University School of Medicine, Saint Louis, Missouri, USA.<br /><searchLink fieldCode="AU" term="%22Baggott+B%22">Baggott B</searchLink>; Department of Gastroenterology, Hepatology and Nutrition, Cleveland Clinic, Cleveland, Ohio, USA.<br /><searchLink fieldCode="AU" term="%22Guthmueller+B%22">Guthmueller B</searchLink>; Global Clinical and Translational Sciences, Ferring Pharmaceuticals, Roseville, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Bancke+L%22">Bancke L</searchLink>; Global Clinical and Translational Sciences, Ferring Pharmaceuticals, Roseville, Minnesota, USA.; Global Clinical Operations US, Ferring Pharmaceuticals, Roseville, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Gamborg+M%22">Gamborg M</searchLink>; Global Biometrics, Ferring Pharmaceuticals, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Steiner+TS%22">Steiner TS</searchLink>; Division of Infectious Diseases, University of British Columbia, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Van+Handel+D%22">Van Handel D</searchLink>; MNGI Digestive Health, Plymouth, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Khanna+S%22">Khanna S</searchLink>; Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229203213%22">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</searchLink> [Clin Infect Dis] 2025 Feb 05; Vol. 80 (1), pp. 43-51.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase III; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9203213 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6591 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210584838%22">10584838 </searchLink><i>NLM ISO Abbreviation: </i>Clin Infect Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39180326
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/cid/ciae437
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 43
    Titles:
      – TitleFull: PUNCH CD3-OLS: A Phase 3 Prospective Observational Cohort Study to Evaluate the Safety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTA) in Adults With Recurrent Clostridioides difficile Infection.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Feuerstadt P
      – PersonEntity:
          Name:
            NameFull: Chopra T
      – PersonEntity:
          Name:
            NameFull: Knapple W
      – PersonEntity:
          Name:
            NameFull: Van Hise NW
      – PersonEntity:
          Name:
            NameFull: Dubberke ER
      – PersonEntity:
          Name:
            NameFull: Baggott B
      – PersonEntity:
          Name:
            NameFull: Guthmueller B
      – PersonEntity:
          Name:
            NameFull: Bancke L
      – PersonEntity:
          Name:
            NameFull: Gamborg M
      – PersonEntity:
          Name:
            NameFull: Steiner TS
      – PersonEntity:
          Name:
            NameFull: Van Handel D
      – PersonEntity:
          Name:
            NameFull: Khanna S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 05
              M: 02
              Text: 2025 Feb 05
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1537-6591
          Numbering:
            – Type: volume
              Value: 80
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
              Type: main
ResultId 1